Clinical trial
A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab…
NCT01770951 · Alexion Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT01770951 |
|---|---|
| Title | A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) |
| Official title | A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) |
| Lead sponsor | Alexion Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Atypical Hemolytic Uremic Syndrome (aHUS) |
| Enrollment | 30 |
| Start date | Aug 31, 2009 |
| Primary completion | Nov 30, 2010 |
| Completion | Nov 30, 2010 |
| First posted | Jan 18, 2013 |
| Last update posted | Aug 18, 2023 |
| Countries | Austria, Canada, France, Germany, Netherlands, Spain, Switzerland, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: